CLDN1 and central nervous system cancer: Reduced CLDN1 expression was observed in glioma cell lines derived from high-grade (grade 3 and 4) tumors, compared to low-grade pilocytic astrocytomas (grade 1), diffuse astrocytomas (grade 2), and non-neoplastic control tissues (43, 44).